Danaher (DHR) March 125 calls active after acquiring the biopharma business of GE Life Sciences

Danaher (NYSE: DHR) March call option implied volatility is at 18, April is at 16; compared to its 52-week range of 14 to 37 after announcing that it has entered into a definitive agreement with General Electric (GE) to acquire the biopharma business of GE Life Sciences for a cash purchase price of approximately $21.4B. Call put ratio 5.3 calls to 1 put with focus on March 125.

You May Also Be Interested In

• Trifecta Gold closes $1.66M private placement for Yukon exploration
• iShares Silver Trust (SLV) spreader of 5K contracts of July 90 and 100 puts
• Otovo acquires SunSystem Technology for up to $1.3M